150 WORDS) Astroglial cells are emerging as key players in the development and homeostatic maintenance of neurons and neuronal networks. Astroglial cell functions are critical to neuronal migration and maturation, myelination, and synapse dynamics, however little is known about astroglial phenotypic changes over development. Furthermore, astroglial cells express steroid hormone receptors and show rapid responses to hormonal manipulations, however, despite important sex differences in telencephalic regions such as the cortex and hippocampus few studies have examined sex differences in astroglial cells in development and outside of the hypothalamus and amygdala. To phenotype cortical astroglial cells across postnatal development while considering potential sex differences, we used translating ribosome affinity purification together with
Introduction
The cerebral cortex is a complex network of layered neuronal cells that uses a balance of excitatory and inhibitory signals to communicate both within the cerebral cortex itself and to lower brain regions 1 . It is the most recently evolved component of the mammalian central nervous system and is uniquely involved in higher order cognitive functions 2 that are central to intelligence and emotional processing. The complex layered structure of the cerebral cortex emerges during embryonic development in an "inside-out" pattern consisting of radial glial cell (RGC)-assisted neuroblast migration to lower layers (i.e. VI) before the upper layers are formed 3, 4 . The appropriate migration of developing neuroblasts is an integral part of the maturation of the cerebral cortex. Early insults or perturbations during this critical period of development may disrupt the gross organization of excitatory and inhibitory networks leading to neurodevelopmental disorders including autism spectrum disorders (ASD) or schizophrenia, and mood disorders such as bipolar disorder 5, 6 . Importantly, even subtle modifications in the number or functionality of cortical synapses may lead to serious behavioural consequences and have been related to a number of psychiatric diseases 7 .
The prevalence of many, if not all, neurodevelopmental disorders and mood disorders related to cortical function are sexually dimorphic in human populations 8 .Thus understanding sex differences in the organization and function of the cerebral cortex is critical to understanding the neurodevelopmental underpinnings of psychiatric disease.
There is a great deal of literature that suggests that gonadal hormones can directly modulate disease states associated with schizophrenia, anxiety and mood disorders 9, 10 .
Similarly, in rodent models, basal changes in behaviours such as in the forced swim task have been demonstrated across the estrous cycle 11 . Together, these data support an important role for ovarian hormones and in particular, estrogen, in mediating those behaviours related to higher order cognitive functioning in situ. Effects on behaviour and physiology that depend on current levels of hormones such as those described above are referred to as activational. The sex steroid milieu of embryonic and neonatal life, however, can also have organizational effects. These are changes induced in this early stage of development that persist even when the hormonal state producing them has dissipated. Testosterone secreted from the testes of XY-male embryos acting either directly or via aromatisation to estradiol is the primary organizing influence in the sexual differentiation of the brain 12, 13 ; The role of estradiol in mediating organizational sex differences through neuronal estrogen receptor (ERs) signaling has been extensively studied in the hypothalamus and amygdala. For example, in the MPOA, estrogen receptor signalling induces prostaglandin-mediated synapse formation through microglial and astroglial-mediated functions 13 . Neuroanatomical and functional sex differences are also well defined in various neuronal populations of the hypothalamus 14 , amygdala 15 , and hippocampus 16 . The cerebral cortex, however, has received less attention than other telencephalic regions 17 .
While it is possible that sex differences in cortical network functioning may be completely mediated by direct hormonal modulation, sex differences in prevalence of anxiety disorders 9 and ASD 18 are apparent prior to puberty, and pro-dromal behaviours associated with psychosis also show sex differences early in development 19 , suggesting that organizational sex differences (presumably in cortical networks) may be involved in differences in risk or vulnerability for psychiatric disease.
Astroglial cells have recently emerged as key mediators in brain development and the etiology of neurodevelopmental and mood disorders has been related to astroglial-mediated functions such as neuroblast migration and synapse formation, maturation, and elimination 20, 21 . Astroglial cells are a heterogenous cell population comprised of three main subtypes. The first subtype of astroglial cells to emerge in development are RGCs 22 . In addition to providing scaffolding for migrating neuroblasts, astroglial cells exhibit stem-like potential in early development and following injury that allows them to give rise to other neuronal cells before maturing and populating the cortex as fibrous or protoplasmic astroglial cells 23, 24 . As astroglia mature, their stem cell potential diminishes, as marked by an increase in glutamate synthetase and decreased expression of Sox2 and vimentin 25 . The two main mature subtypes are characterized as protoplasmic; canonical astroglia with large domains of many fine processes, and fibrous; astroglial cells with many long fibrous extensions 26 . These mature astroglial cell populations are responsible for the construction and maintenance of both excitatory 27 and inhibitory 28 synapses in the developing neocortex, modulating neuron signaling and maturation 29 , and the elimination of synapses during cortical maturation 21 . Work from the Barres laboratory characterised astroglial cells in brain development using next generation sequencing techniques, however these studies did not examine the contributions of biological sex, or early developmental periods 30 . Astroglial cells express ERα 31 , ERβ 32 , and G-protein coupled ERs 33 , and although the full extent of ER functionality in astroglial cells is not understood 34 , astroglia show rapid responses to hormones across various states and manipulations 35 .
Because astroglial cells contribute to cortical development through neuroblast migration, neuronal network integration, and synapse formation, maturation and elimination, and because astroglia show rapid responses to hormones, we hypothesized that cortical astroglial cells may 1) show phenotypic sex differences both overall and across development and 2) execute developmental functions in a sexually dimorphic way. To address this, we employed a transgenic mouse model expressing enhanced green fluorescent protein (eGFP) fused to the L10 ribosome under the pan-astroglial cell promoter AldH-L1 and used immunohistochemistry and TRAPseq to phenotype the astroglial translatome and protein expression. We examined time points pertaining to critical periods of postnatal neocortical development.
Results
To measure total numbers of neocortical astroglial cells (astroglial cell number) across development, we used unbiased stereology to quantify eGFP+ cells (eGFP was expressed under the control of the pan-astroglial promoter, (AldH-L1). No sex differences in total astroglial number were observed (F=0.186; p=0.966) ( Figure 1A) , however there was a main effect of age on this measure (F=55.544, p<0.001), whereby the number of astroglial cells did not show further increase in males or females after P14 ( Figure 1A ). Neocortical volume did not exhibit sexual dimorphism (F=0.302, p=0.909) ( Figure 1B ). Not surprisingly, we observed a significant increase of brain volume with age (F=135.181, p<0.001) ( Figure 1B ).
Astroglial cell phenotype was assessed by looking at protein expression of common astroglial markers and characterising morphology. Astroglial cells show morphological heterogeneity that is often associated with functionality (Sofroniew & Vinters, 2010) . In order to assess changes in morphology across age and/or sex, eGFP+ cells were characterized as radial or non-radial based on the presence of a leading, radial process in the neocortex. No significant sex effects were found (F=0.249, p=0.938), however there was a significant effect of age (F=89.291, p<0.001) ( Figure   1C ). Nearly all (~95% in both males and females) astroglial cells in the neocortex at P1 exhibited radial morphology ( Figure 1C ). At P4, there was a marked decrease in the proportion of radial astroglial cells and most cells shifted to a non-radial morphology with no marked sex differences. By P7, only 5% of astroglial cells in males and 4% of astroglial cells in females exhibited a radial morphology and, as expected, from P14 onwards there were virtually no radial astroglial cells remaining in the neocortex (<1%) ( Figure 1C ). We quantified expression of the astroglia-specific cytoskeletal filament protein glial acidic fibrillary protein, (GFAP). GFAP expression was not sexually dimorphic across development (F=0.204, p=0.959) however, there was a main effect of age (F=30.328, p<0.001) ( Figure 1D ). The number of GFAP+ cells reached peak levels at P14 and remained stable at later timepoints ( Figure 1D ). Prior to P14, no more than 15% of eGFP+ cells co-expressed GFAP, from P14-onwards approximately 25% of eGFP+ cells expressed GFAP, consistent with previous work that has demonstrated that a large proportion of cortical astroglia do not express GFAP under basal conditions (Simard et al., 2018) .
Next, we quantified the number of cells that expressed vimentin, an intermediate filament protein associated with a stem-like radial sub-type of astroglial cells. A significant interaction of sex by age was found (F=3.871, p=0.006) ( Figure 1E ), such that females showed significantly more vimentin+ cells compared with males at P7 (t=3.41, p=0.011) and males showed significantly more vimentin+ cells in adulthood (t=3.895, p=0.005) ( Figure 1E ,G). Because vimentin expression is associated with astroglial cell neurogenic and stem cell potential and because we observed sex differences in vimentin expression, we quantified the proportion of actively dividing eGFP+ cells across the postnatal period. Using a marker of active s-phase cell division, Ki67, we quantified the percent of Ki67+eGFP+ cells. Ki67 was present in less than 2% of the astroglial cell population throughout the postnatal period in both males and females ( Figure 1F ). There were no significant sex differences across development (F=1.608, p=0.179) however there was a main effect of age (F=26.799, p<0.001).
To generate a complete phenotype of astroglial cells across development by sex, we used TRAPseq to assess the astroglial translatome at each time point. In order to further characterise astroglial-specific markers by sex and age, we plotted expression data for each of the top 20 genes expressed only in astroglia as described in 30 ( Figure   2 ). Interestingly, most astroglia-specific genes are expressed at slow-rising or stable levels across development, however CYP4F14, a Vitamin E hydoroxylase and SLC39A12, a zinc transporter involved in the pathophysiology of schizophrenia 36 both have low expression levels early on and rise to adult levels at P14. We did not find any sex differences in astroglia specific genes. Figure 3A shows the hierarchical organization of the astroglial translatomes by sample. Overall, the clustering shows a pattern of organization that is primarily affected by age, with P1, P4 and P7 (early) showing similar expression patterns and P14, P35 and adult mice (late) showing similar expression patterns that differ from the early timepoints. We manually sorted samples by sex and age and although some organization by sex is noted in Figure 3B , this is not as clearly demarcated as that observed by age. Indeed, when we collapsed gene expression levels across all time points, 43 genes were differentially expressed between female and males (Supplementary Data File 1) in total, suggesting little to no sex differences in cortical astroglia overall. Moreover, many of these sex differences in gene expression are for genes located on the sex chromosomes. These findings suggest that overall, the basal translatome of cortical astroglia is not sexually dimorphic and that there are two major cortical astroglial phenotypes across age: an early (P1-P7) and late (P14-adult) phenotype.
To further characterize the "early" and "late" phenotype observed in the astroglial cell translatome, we examined the number and proportion of up-and downregulated genes in the early versus late developmental phenotypes, both by sex and collapsed across sex ( Figure 4A ). The early versus late phenotype in males showed 5528 DEGs whereas the female early versus late phenotype had 8593 DEGs (full list of DEGs in Supplementary Data File 2). Interestingly, the proportion of up-or downregulated genes was fairly equal, with males and females showing 56% and 55% of DEGs in the early versus late phenotype being upregulated, respectively. When we collapsed the DEGs across sex to generate a general astroglial cell early vs late phenotype, the number of DEGs reaches 9219, distribution of up-(58%) and downregulation (42%) ( Figure 4A ).
This suggests that the difference in the early and late developmental phenotype is not merely reflective of turning off developmental genes but rather is a combination of downregulating genes associated with early development and turning on genes associated with later development and early adulthood.
Some key DEGs stand out as they have not previously been functionally described in astroglial cells. In particular, Trim67, an important and evolutionarily preserved guidance cue for neurite outgrowth 37 , is high in early development and, as expected, decreases with age. This gene is also upregulated at P7 in females compared to males (Supplementary Data File 1 & 2). Additionally, Ntng1, codes for Netrin G1, another guidance cue that is paramount to developing neuroblasts, is higher during the "early" developmental phenotype in astroglial cells. Interestingly, differential Ntng1 expression appears when examining both the overall and the female-specific early versus late astroglial cell phenotype, however it does not seem to be differentially regulated in the male-specific early versus late astroglial cell phenotype. Ntng1 has been implicated in the etiology of familial schizophrenia 38 and Ntng1 mRNA is in lower cortical samples from individuals with schizophrenia and autism 39 .
Next, we compared the proportion of overlap between the female-specific and male-specific DEGs in the early versus late phenotype, and a clear sex difference emerges in the developmental expression pattern of astroglia. Of the 9219 DEGs, approximately 55% overlap between males and females, however a staggering 39.4% of total DEGs are specific to females and 10% are specific to males ( Figure 4B ). This suggests that there are distinct developmental phenotypes in cortical astroglial cells that emerge between the sexes. When we further characterize the sex-specific canonical pathways (CPs) by gene set over-representation, a large proportion of the top 10 female-specific CPs are related to cell cycle/mitosis, marked by CPs related to M-Phase of cell division, "Mitotic, Cell Cycle," mRNA processing, and Wnt signalling ( Figure 4D ).
In comparison, male-specific CPs are related to ion homeostasis, small molecule transportation, and adenosine triphosphate regulation ( Figure 4C ). In particular, we see "prostaglandin synthesis and regulation" in male, but not female CPs. Prostaglandins are essential mediators in sexual differentiation of the hypothalamus and amygdala 13 .
The emergence of the prostaglandin CP in the cortex suggests that prostaglandins may also be regulators of neocortical sexual differentiation.
To broaden the understanding of sex differences in astroglial cell gene expression across development, we identified DEGs of females versus males at each time point ( Figure 5A ). At P1, there are only 14 DEGs however at P7, P14, and P35 there are 193, 134 and 176 DEGs, respectively ( Figure 5A ; full list of DEGs in Supplementary Data File 1). In Figure 5B we show the number of DEGs between developmental time points in males and females, the peak in DEGs in males occurs between P4-P7, with 507 DEGs whereas the peak number of DEGs in females is between P7 and P14 and is substantially larger, with 3113 genes differentially expressed at this timepoint. These sex differences between P4-P14 are particularly striking given that these are the developmental timepoints where sex hormones are largely dormant ( Figure 5D ; full list of DEGs in Supplementary Data File 3), suggesting that these sex differences in gene expression were induced by earlier exposure to hormones or by sex-linked chromosomes. Remarkably at P7, P14, and P35, 85%, 66%, and 98% of DEGs are downregulated in females. Within these downregulated genes are typical markers of cell activity, Fos and Arc, suggesting decreased basal activity in female astroglial cells at these timepoints (Supplementary Data File 1).
Work from the McCarthy laboratory has previously demonstrated that prostaglandins, and in particular, glial release of cyclooxengase 2 (COX-2) is a key regulator of estrogen-mediated architectural sex differences in the hypothalamus and the amygdala 40, 41 . The gene for COX2, Ptgs2, is a sex-specific DEG in our data set in the overall females versus males, in the early female versus male phenotype, and at P1 female versus male (Supplementary Data File 1 & 2). COX2-mediated masculinization of the hypothalamus occurs in response to estradiol, which is aromatised from the surge in testosterone in males that occurs perinatally in rodents ( Figure 5D ). This perinatal surge in testosterone has been linked to sexual differentiation of the hypothalamus, amygdala, and mediates sexually dimorphic juvenile and adult behaviours [42] [43] [44] . To validate our findings and to test if COX2 protein levels are similarly regulated by estrogen in the cortex, we subjected P0 females to estradiol benzoate injections and sacrificed them 36 hours later. Females at P1 show fewer COX2+ cells in the frontal cortex compared to males and females exposed to estrogen (F=3.509, p=0.034) ( Figure   5C ). This suggests that estrogen exposure at P0 is sufficient to masculinize COX2 expression the cortex.
Next, we integrated the different altered gene sets in a coherent, systems-level context, using co-expression network analysis (see Online Methods). We inferred, (separately) a co-expression network in females and males throughout development, and identified 12 and 14 co-expression modules, respectively. We then characterized the modules in terms of overlap with the DEGs in the late vs early phenotype, correlation with developmental time point, and enrichment in GO terms and canonical pathways.
In females, the blue, brown, magenta and pink modules are enriched in genes upregulated in late vs early in females, and the black, turquoise and yellow modules are enriched in genes downregulated in late vs early in females (see WGCNA Summary data). Interestingly, the blue and brown (upregulated), and the black (downregulated) modules are enriched in astrocyte genes. The turquoise module (downregulated) is enriched in cell cycle terms, and the yellow module (downregulated) is enriched in genes involved in ligand-receptor interaction, probably in relationship to cell cycle.
In the males' network, the black, blue, brown, magenta, pink and tan modules are enriched in genes upregulated in late vs early in males, and the green, red and turquoise modules are enriched in genes downregulated in late vs early in males (see Table WGCNA ). Similar to what was observed in the female network, some of the modules enriched in upregulated genes in the late vs early phenotype in males (black, blue and brown), are enriched in astrocyte genes. It is likely that, in both networks, the astrocyte signature for the modules enriched in upregulated genes reflects a shift in astroglial phenotype during development. Finally, the green and turquoise modules (downregulated) are enriched in cell cycle terms. The cell cycle signature for some of the downregulated modules likely reflects a reduction of proliferative potential of the cells over time, as would be expected over development.
Next, we tested each network, female and male, for enrichment in DEGs related to the opposite sex, to identify differentially enriched modules that might point to sexspecific modules, and, potentially to sex-specific regulation processes. In the female network, we found that one module, black, is enriched in downregulated DEGs in late vs early phenotype in female, but not in male DEGs. Further annotation of the black module highlights enrichment in genes defined as response to androgen (MSigDB:Hallmark) and genes downregulated in response to estradiol treatment in mouse (EnrichR: GSE52649).
The relationships are more complex in the male network however, we find differential enrichment with both upregulated and downregulated DEGs. The tan module overlaps with upregulated DEGs in males, but not in females, which instead overlap with the yellow module. Further annotation of the tan modules shows enrichment in genes upregulated after treatment with testosterone in human skeletal muscle cells (EnrichR:GDS2920). In addition, the red module overlaps with downregulated DEGs in males, but not in females, which instead overlap with the purple module. Further annotation of the red modules shows enrichment in cell cycle genes and defining early response to estrogen (MSigDB:Hallmark); also with genes downregulated after
Discussion
In the current study, we generated a translatome database of cortical astroglial cells across development in both male and female mice. We show two clear astroglial phenotypes across development, an early (before P14) and late (after P14) phenotype.
These early and late gene expression profiles reflect astroglia associated with early developmental functions related to gliogenesis and synaptogenesis and astroglia associated with functions involved in maturation, synapse elimination and maintaining a stable, homeostatic environment in adulthood ( Figure 5D) . Surprisingly, cortical astroglial cells showed very little sexual dimorphism in either morphology or gene expression particularly in adulthood where very few DEGs were not sex-chromosome associated genes. Importantly, to assess basal differences between males and females in a conservative way, we chose to examine females during the metestrus phase, when ovarian hormones are at their lowest and therefore more similar to levels observed in males. As such, it is likely that greater sex differences in the astroglial translatome would be observed during other estrous cycle phases, such as in proestrus, when estrogen peaks. Indeed, we have previously demonstrated changes in cortical astroglial expression of GFAP and fibroblast growth factor 2 (FGF2), an astroglial mitogen and growth factor across the estrous cycle 45 . Together these results would suggest that astroglial cells show phenotypic changes in response to ovarian hormones, but they do not show basal sexual dimorphism.
Interestingly, the sex differences in DEGs observed at P7, 14, and 35 were not related to sex-specific canonical pathways or functions per se, but rather, they were related to general developmental phenomena such as cell cycle, and neuronal, dendritic and synaptic development, suggesting that astroglia modulate neuronal networks in a sexually dimorphic way. This could, in turn, potentially lead to the formation of sexually dimorphic neuronal networks, and presumably, sexually dimorphic behavioural expression later in life. Given the critical role of the neocortex in psychiatric disease and complex human behaviours 46 , one might imagine that changes in neuronal network development may be induced by estrogen-modulated changes in astroglia. In addition, these may be particularly susceptible to developmental perturbations that modulate hormone expression levels including exposure to stress hormones and environmental endocrine disruptors. Moreover, because hormone levels vary between individuals under normal conditions, this allows for a potential range of sexual differentiation of cortical networks, which would mirror behavioural sex differences observed across species, that are typically expressed on a continuum.
In contrast to the sex differences in gene expression seen on P4-P35, we see few DEGs between astroglia in male and female mice at P1 and in adulthood. This, in addition to the sex differences in CP of early versus late astroglial phenotype, suggests that cortical astroglial cells employ different developmental strategies to reach a similar phenotype. The idea that distinct mechanisms might lead to similar functional results is similar to that put forward by Woolley 47 , which was based on findings of estradiol potentiating glutamatergic synapses, albeit on a much more general level. Earlier DeVries 48 postulated that sex differences in gene expression patterns over development may actually prevent sex differences in specific regions or ensure that neuronal systems develop and are functional in the presence of cues such as sex hormones that are crucial for stimulating sex differences in target regions. It is possible that the sex differences in gene expression profiles between astroglia ensure that these systems develop "equally" in both sexes to achieve similar functionality in adulthood in the presence of sex chromosomes and hormones that are necessary to differentiate regions critical to sexually dimorphic behaviours, such as the hypothalamus.
The question remains as to what induces sex differences in cortical astroglia gene expression patterns over development. Three potential scenarios emerge: 1) sex chromosome-linked genes directly induce changes in gene expression patterns in astroglia, 2) the perinatal testosterone surge initiates cascades of gene expression patterns in astroglia that modulate cell maturation and network development, and 3)
given that astroglial cells have similar start and end points, and that sexual differentiation of the hypothalamus includes dramatic changes in neuronal number, arbours, and synapses, and that these project to other brain regions (including the neocortex), sex differences in astroglia gene expression could represent an active process to compensate for the influence of sex differences in developing inputs.
Importantly, these scenarios need not be mutually exclusive and may be active in parallel systems.
Kdm5d appears as one of the few DEGs between females and males at P1 in our dataset, female expression levels are lower than males. Kdm5d is a Y-linked gene that encodes for demethylation enzymes and is required and sufficient to induce sexual differentiation of gene expression 49 . Indeed, changes in gene methylation may have profound effects that persist throughout time and cascades of gene expression may or may not be initiated, altering the responsiveness of the cell, and thus the network as a whole. Moreover, even in the absence of the testes determining Sry gene, the Ychromosome has been shown to exert differential effects on developing peripheral and nervous tissue (reviewed in 50 ), lending support to the idea that sex chromosome linked genes induce later sex differences in astroglia across development.
Similarly, there is evidence that the perinatal testosterone surge, and consequentially, estrogen is involved in the induction of developmental sex differences in astroglia (scenario 2). Our weighted network analysis shows enrichment of genes in several modules associated with responses to sex hormones and we show sex differences in the prostaglandin system (including Cox2) and that neonatal estrogen administration induces changes in cortical COX2 expression. Similar changes in astroglia have been demonstrated in the hypothalamus and are sufficient to produce observable sex differences in neuronal networks and associated behaviour 13 . Thus, the endogenous expression of estrogen early in development may facilitate a cascade of cellular maturation that in-turn will alter subsequent genetic programs. As such, the neuronal network will facilitate different programs as a result of the staggered pattern of maturation and communication.
Finally, scenario 3 suggests that sex differences in the hypothalamus are necessary for a functional behavioural outcome that is overt and essential for sexual reproduction, first suggested by de Vries 48 . However, there are few overt measures that can be linked to cortical functioning that exhibit similar sexual dimorphisms, although sex differences in risk and resilience for psychiatric disease associated with cortical functioning are well-supported. For example, schizophrenia and ASD are more prominent in the male population 8 
and both show changes in developmental
pathophysiology that occur both during the prenatal and postnatal periods 51, 52 . There may be a relationship between astroglial neurogenic potential and the terminal phases of neuronal migration and construction and maturation of functional cortical networks that buffers females against developmental anomalies which, if left unchecked, may lead to schizophrenia or ASD morbidity.
In-line with this hypothesis, there are a number of models where estrogen treatment improves recovery or where females are protected in developmental injury models. Chronic postnatal hypoxia in rodents is used as a model of premature birth and induces loss of brain volume, particularly in the cortex and hippocampus, and leads to motor and cognitive impairments later in life 53, 54 . The loss of cortical volume in the hypoxic model is less pronounced in females 53 and interestingly, estradiol treatment at the time of the injury improves white matter damage recovery 55 . It is also known that chronic postnatal hypoxia increases astroglial stem cell capacity 23, 56 . This process may be enhanced in females allowing augmented recovery from the aversive effects of hypoxia, but may also speak to the nature of enhanced early postnatal plasticity in females compared to males. It is possible that females experience an enhanced or shifted neurogenic period early postnatally when we have observed an increase in vimentin+ astroglia that may translate to increased neurogenic potential of astroglial cells in the cortex. Similarly, while overt network or cellular sex differences may not modulate sex differences in risk for psychiatric disease, sex differences in developmental programs may leave one sex more vulnerable to perturbations during that time. Future studies will be needed to determine the functional significance of sex differences in developmental programs. Nevertheless, our data show a clear developmental pattern in cortical astroglia that differs between males and females, while no apparent basal sex differences in astroglia exist. 
Online Methods

Animals
Estrous Cycle Monitoring
All adult group female animals were monitored daily after P35 to identify stage of estrous cycle using a saline lubricated swab inserted into the opening of the vagina to collect cells from the vaginal wall. Samples were smeared on a glass microscope slide and examined under a 10x objective using a light microscope (VistaVision TM ). To understand basal organizational sex differences in astroglia, we used female mice in the phase of the estrous cycle with the lowest circulating ovarian hormones that has the least effect on cortical astroglial morphology and protein expression: metestrus 57 . After the stage of estrous cycle (Metestrus, Diestrus, Proestrus and Estrus) had been established for at least two full cycles, females were sacrificed during the light cycle of the metestrus stage.
Organizational hormones-injections
Estradiol benzoate (Chem Cruze, sc-205314) was dissolved in peanut oil 
Animal Sacrifice
Rapid Decapitation for immunohistochemistry and qPCR-Animals in the P1 immunohistochemical group were rapidly decapitated and brains immediately placed in a 4% paraformaldehyde (Fisher Scientific) (PFA) solution at 4 ºC for 24h after which the brains were switched to 30% sucrose at 4 ºC for 24h. Following this period, brains were flash frozen until slicing. For the organizational hormone experiment, pups underwent rapid decapitation 36h following treatment. Brains were harvested and split along the central fissure. One hemisphere was flash frozen at -80°C for analysis in qPCR and the other hemisphere was fixed as above.
Cardiac Perfusion for Immunohistochemical Analysis-All mice were sacrificed for tissue collection at the same time of day during the light cycle. All mice in the immunohistochemical group underwent cardiac perfusion aside from those in group P1 (see above). Animals in P4, P7, P14, P35 and adult groups were given an overdose of 44mg/kg sodium pentobarbital (CDMV Canada), followed by intra-cardiac perfusion upon all spinal reflex cessation. Animals from the P4 and P7 groups underwent manual cardiac perfusion with 1mL of saline solution before receiving 1mL of 4% PFA via syringe. Mice in the P14, P35, and adult groups blood were flushed using 10mL of saline through the left atrium followed by 20mL of 4% PFA to fix the tissue. Brains were extracted and placed into vials containing 4% PFA and stored at 4 ºC. Following a 24h period, brains were transferred to a 30% sucrose in PBS (Fisher Scientific) solution and placed at 4 ºC.
Tissue sectioning
Following sucrose treatment, all brains were then flash frozen at -80 ºC until sectioning on a Leica (Leica TM CM1900) cryostat (30μm thick). 15 sets of sagittal sister sections were adhered to electrostatic slides (Fisher Scientific TM ) in rotating order, each slide therefore contained a full representation of the brain for stereological analysis as per previous studies 56, 59 .
Immunohistochemistry
All immunohistochemical processes took place at room temperature (~21 ºC) as per our previous studies 23, 56, 60 . One representative slide was taken from every subject and all subjects were processed simultaneously. Brain tissue from all groups were 20 prepared for immunohistochemistry using a 10% horse serum (Gibco TM ) PBS-T (0.3% TritonX (Fisher Scientific)) pre-block solution for 1 hour before being incubated with the respective primary antibody solution (see Supplementary Figure 1 ). Primary antibodies were diluted in 10% horse serum PBS-T (0.3% TritonX). Following approximately twenty-four hours of primary antibody incubation, slices were washed in a 1x PBS solution 3 times to remove unbound antibodies before being incubated with the speciesappropriate fluorescein conjugated secondary antibody for visualization. Secondary antibodies were diluted in 10% horse serum PBS-T (0.3% TritonX) and incubated for 2 hours before slides were submerged in a 1x PBS wash 3 times to remove unbound antibodies. Slides were then coated with a nuclear stain, DAPI with hard setting mounting medium (VectorLabs), to fix glass cover slips and allowed to set before analysis. See Supplementary Figure 1 for antibodies and dilutions used.
Stereological Analysis
Unbiased estimates of cell numbers were obtained through use of Zeiss AxioImager M2 with ApoTome motorized fluorescent microscope (Carl Zeiss, Thornwood, NY, USA) in conjunction with a motorized stage and a computer running on 
Statistical Analysis
All immunohistochemical and qPCR data were analyzed for using a 2 (male vs.
female) x 6 (P1 vs. P4 vs. P7 vs. P14 vs. P35 vs. Adult) between-subject factorial analyses of variance (ANOVA) design using IBM SPSS Statistics (Version 20.0).
Because the treatment differed in males and females, for the organizational hormones study we employed a one-way ANOVA to determine overall significance. Post-hoc analysis using Bonferroni correction of pairwise comparisons for non-orthogonal comparisons were conducted when p<0.05. We re-ran all of the statistics including litter composition (male vs. female) as a covariate and found no significant effects of litter on any of the variables measured (data not shown).
RNAseq data analysis. Sequencing reads were mapped to the mouse genome (GRCm38.p5) and the Ensembl (releas-84) transcriptome annotation, using HISAT2
[doi: 10.1038/nprot.2016.095]. The mapping rates ranged from 74% to 95%. This resulted in a number of mapped pairs from ~19.5 million up to 40 million (see Supplementary Table QC for more details). The resulting SAM files were converted to BAM formant using SAMtools 63 . The gene expression levels as counts were estimated using featureCounts 64 with the following options: -t exon; -g gene_id; -F "GTF"; -B; -s 0; -p; -a. Raw read counts were filtered requiring more than 1 CPM (counts per million) in at least 25% of the samples and 16214 survived the filter and were considered for further analysis. Conditional Quantile Normalization (cqn package ver 1.16.0) 65 was used to correct for GC bias normalize counts and also to generate normalized RPKM.
We next used the sva Bioconductor package [ 10.1093/bioinformatics/bts034] to identify and correct for latent variables. Hierarchical clustering (using the genes with a sd in expression level above the 95%) pre-and post sva correction show the sample-tosample relationship and relative clustering (see Supplemental Figure 2 ). FastQC v0.10.1 and RNA-SeQC (v1.1.8) were used for QC (see Supplemental Table QC) .
Differential expression analysis. Differential expressed genes were then inferred using the edgeR pipeline 66 Weighted gene co-expression network analysis. We used Weighted Gene Coexpression Network Analysis (WGCNA) 68 for co-expression network analysis using gene expression estimates (as log2(RPKM+1)), separately, from the 25 male samples and the 26 female samples, after cqn and sva correction. We estimated a male and female the co-expression network and modules using the function blockwiseModule, using the bicorr as correlation estimate, a "signed" network type and a minModuleSize=50. The power cut-off was set to 16 for both sets. The analysis produced a male network of 12 modules and a female network of 14 modules, including the grey module of unassigned genes (See WGCNA Summary Data). 
Figure Captions
